Kristina M. Broadbelt
Public Communications Contact bij Shire ViroPharma, Inc.
Actieve functies van Kristina M. Broadbelt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Public Communications Contact | 17-06-2010 | - |
| Algemeen Adviseur | - | 03-05-2012 | |
| Corporate Officer/Principal | 17-06-2010 | 31-08-2010 |
Loopbaan van Kristina M. Broadbelt
Statistieken
Internationaal
| Verenigde Staten | 2 |
Operationeel
| Public Communications Contact | 1 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
